Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders (NCT06622993) | Clinical Trial Compass
RecruitingNot Applicable
Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders
France60 participantsStarted 2024-11-14
Plain-language summary
Epidemiological studies show that one person in eight suffers from at least one psychiatric disorder. Mental health is therefore a major public health issue, and care for these disorders must continue to be improved.
The management of mental disorders has long followed the traditional categorical approach of developing a treatment for a given disorder. However, researchers have recently pointed out the limits of this approach in the field of mental health. They highlight the large number of co-morbidities, the existence of aspecific disorders and the intra-diagnostic heterogeneity of patients. These factors have led them to develop a transdiagnostic approach, which focuses on the mechanisms common to the various disorders in order to treat them at the same time and thus reduce the cost of treatment.
Who can participate
Age range
18 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female ≥ 18 years of age
* Have at least one diagnosis of a psychiatric disorder
* Be able to carry out psychotherapy sessions
* Have been on stable psychiatric medication for 30 days
* Written informed consent obtained from the participant
* Be affiliated to a social security scheme or equivalent
Exclusion Criteria:
* Cognitive deficits marked by a score above the 10th percentile for one or more tests in the assessment history.
* Persons deprived of liberty by judicial or administrative decision; Persons under legal protection: guardianship or curatorship
* Presence of a severe depressive episode
* Be engaged in psychotherapeutic work elsewhere
* Presence of a state of excessive deficit, making psychotherapy impossible
* Presence of psychic decompensation (e.g. delusions) making psychotherapy impossible
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Evolution in Symptom Checklist Scale (SCL 90) scores between randomization and Month 3